Review The Emerging Profile of Cross-Resistance among the Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors

Review The Emerging Profile of Cross-Resistance among the Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors

Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are widely used to treat HIV-1-infected individuals; indeed most first-line antiretroviral therapies typically include one NNRTI in combination with two nucleoside analogs. In 2008, the next-generation NNRTI etravirine was approved for the trea...

Full description

Bibliographic Details
Main Author: Nicolas Sluis-Cremer
Format: Article
Language:English
Published: MDPI AG 2014-07-01
Series:Viruses
Subjects:
HIV
reverse transcriptase
nonnucleoside inhibitors
nevirapine
efavirenz
rilpivirine
etravirine
dapivirine
MIV-150
Online Access:http://www.mdpi.com/1999-4915/6/8/2960

Internet

http://www.mdpi.com/1999-4915/6/8/2960

Similar Items